Risk factor patterns for cryptorchidism and hypospadias

被引:188
作者
Akre, O
Lipworth, L
Cnattingius, S
Sparén, P
Ekbom, A
机构
[1] Karolinska Inst, Dept Med Epidemiol, S-17177 Stockholm, Sweden
[2] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
cryptorchidism; hypospadias; etiology; pregnancy; intrauterine growth retardation; sex hormones; estrogen;
D O I
10.1097/00001648-199907000-00005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
To evaluate the hypothesis of a common etiology for cryptorchidism and hypospadias, we conducted two case control studies nested in a nationwide cohort in Sweden, using record linkage between the Inpatient and Birth Registries. Cases were 2,782 and 1,220 boys operated for cryptorchidism or hypospadias, respectively. Five matched controls per case were randomly selected. Pregnancy and perinatal data were prospectively recorded in the Birth Registry. Data were modeled through conditional logistic regression. Both cryptorchidism (odds ratio (OR) = 2.22) and hypospadias (OR = 2.75) were positively associated with other congenital malformations and inversely with maternal parity (OR = 0.77 and 0.52, respectively, for parity 4+ compared with primiparae). There is evidence that being born small-for-gestational-age and before the 33rd gestational week have a greater than additive effect with respect to both cryptorchidism (OR = 6.19 vs 1.72 expected) and hypospadias (OR = 4.39 vs 2.60 expected) compared with non-small-for-gestational-age boys born at term. Hypospadias was positively associated with severe pre eclampsia (OR = 2.11). We conclude that the etiologies of the two conditions are partly shared.
引用
收藏
页码:364 / 369
页数:6
相关论文
共 37 条
[1]
Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P20
[2]
ANGERPOINTNER TA, 1984, Z KINDERCHIR, V39, P112
[3]
[Anonymous], 1991, CONG MALF WORLDW REP
[4]
NICOTINE, COTININE, AND ANABASINE INHIBIT AROMATASE IN HUMAN TROPHOBLAST INVITRO [J].
BARBIERI, RL ;
GOCHBERG, J ;
RYAN, KJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1727-1733
[5]
Fetal growth and placental function [J].
Bauer, MK ;
Harding, JE ;
Bassett, NS ;
Breier, BH ;
Oliver, MH ;
Gallaher, BH ;
Evans, PC ;
Woodall, SM ;
Gluckman, PD .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 140 (1-2) :115-120
[6]
CRYPTORCHISM AND MATERNAL ESTROGEN EXPOSURE [J].
BEARD, CM ;
MELTON, LJ ;
OFALLON, WM ;
NOLLER, KL ;
BENSON, RC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (05) :707-716
[7]
MALIGNANT POTENTIAL OF THE CRYPTORCHID TESTIS [J].
BENSON, RC ;
BEARD, CM ;
KELALIS, PP ;
KURLAND, LT .
MAYO CLINIC PROCEEDINGS, 1991, 66 (04) :372-378
[8]
Risk factors for cryptorchidism: A nested case-control study [J].
Berkowitz, GS ;
Lapinski, RH .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 1996, 10 (01) :39-51
[9]
MATERNAL AND NEONATAL RISK-FACTORS FOR CRYPTORCHIDISM [J].
BERKOWITZ, GS ;
LAPINSKI, RH ;
GODBOLD, JH ;
DOLGIN, SE ;
HOLZMAN, IR .
EPIDEMIOLOGY, 1995, 6 (02) :127-131
[10]
BROMWICH P, 1994, BMJ-BRIT MED J, V2, P19